BiotechTube

AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + Prednisolone

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety

Conditions

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Healthy Subjects, Rheumatoid Arthritis

Trial Timeline

Nov 18, 2015 โ†’ Sep 26, 2016

NCT ID
NCT02512575

About AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + Prednisolone

AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + Prednisolone is a phase 1 stage product being developed by AstraZeneca for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT02512575. Target conditions include Safety, Tolerability, Pharmacokinetics.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02512575Phase 1Completed

Competing Products

20 competing products in Safety

See all competitors
ProductCompanyStageHype Score
LPH-5 + PlaceboBiotrialPhase 1
25
DS-1971 + placeboDaiichi SankyoPhase 1
33
ASP7962 + PlaceboAstellas PharmaPhase 1
33
ASP2151 + Valacyclovir + PlaceboAstellas PharmaPhase 1
33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solutionAstraZenecaPhase 1
33
Anifrolumab SC injection (300mg) + Anifrolumab IV infusion (300mg) + Anifrolumab SC infusion (600mg) + Anifrolumab placebo SC injection (300mg) + Anifrolumab placebo IV infusion (300mg) + Anifrolumab placebo SC infusion (600mg)AstraZenecaPhase 1
33
AZD7594 + Placebo to matchAstraZenecaPhase 1
33
Anastrozole ODF + Arimidex tablet + Anastrozole ODF + Arimidex tabletAstraZenecaPhase 1
33
AZD4721 Solution + AZD4721 Placebo + AZD4721 SuspensionAstraZenecaPhase 1
33
AZD9977, oral suspension + Placebo, oral suspension + AZD9977, oral solutionAstraZenecaPhase 1
33
AZD3043AstraZenecaPhase 1
33
AZD8848 + Placebo to match AZD8848AstraZenecaPhase 1
33
AZD7503 + PlaceboAstraZenecaPhase 1
33
Fluad + SalineNovartisApproved
85
TBM100NovartisApproved
85
VIB9600 + PlacebosAmgenPhase 1
32
DenosumabAmgenPhase 3
76
Cadonilimab Combined Albumin-paclitaxel, Cisplatin and FluorouracilAkesoPhase 2
51
HTL0018318 + Placebo oral capsuleNxera PharmaPhase 1
32
Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + PlaceboBayerApproved
82

Other Products from AstraZeneca

QuetiapineApproved
85
Dapagliflozin 5 mg + Placebo tabletApproved
85
QuetiapineApproved
85
Ticagrelor + ClopidogrelApproved
85
DurvalumabApproved
85